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Abstract
Background: Hepatocellular adenomas are the most common benign liver tumors. They are
usually related to oral contraceptive intake.
Case presentation: This case describes a 58-year-old woman admitted to our institution for a
hepatic mass incidentally discovered during a routine examination. The patient, who was never on
oral contraceptives, was asymptomatic upon admission. She underwent a thorough diagnostic
evaluation and then a hepatic right trisegmentectomy. The histologic evaluation of the mass showed
that it was a hepatocellular adenoma with areas of bone marrow metaplasia.
Conclusion: Bone marrow metaplasia has rarely been found associated to liver tumors. The
presence of marrow-derived hepatic progenitor cells might be the source of both adenoma
hepatocytes and bone marrow differentiated cells. To our knowledge, this is only the second case
in the English literature in which areas of bone marrow metaplasia were found in a hepatocellular
adenoma.
Background
Hepatocellular adenomas are considered the most com-
mon benign liver tumors. They are proliferative lesions
arising from hepatocyte. They occur primarily in women
between 20 to 40 years of age and are usually related to
oral contraceptive intake. Even though the hepatic ade-
noma is not a malignant tumor, surgical intervention may
be required to establish a histological diagnosis of the
liver mass or if sudden massive bleeding or liver failure
occurs. In the present case, the microscopic observation of
the surgical specimen showed areas of bone marrow
metaplasia within the lesion. To our knowledge, this is the
second case in the English literature in which areas of
bone marrow metaplasia were found in a hepatocellular
adenoma. We, therefore, attempted to give an explanation
to this observation.
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An asymptomatic 58 year-old woman was referred to this
institution for a liver mass detected by abdominal ultra-
sonography (US) during a routine examination. The US
showed a hypoechoic mass with calcifications and multi-
ple non-homogeneous areas in the right hepatic lobe. Her
past medical history was unremarkable. The menarche
was at the age of 13, menstrual periods were regular. Phys-
iologic menopause occurred when she was 49 years old.
She had no history of drug or alcohol abuse. Physical
examination was unremarkable.
Liver function tests and urine analysis were within normal
limits. Hepatitis B surface antigen, anti-HBs antibody and
anti-hepatitis C virus antibody were negative. Serum
tumor markers (CEA, CA 19–9 and α-fetoprotein) were
also negative. Moreover, laboratory and serology data
ruled out liver abscess, amebae or hydatid cyst.
Abdominal computer tomography (CT) showed a volu-
minous lesion measuring 142 × 126 × 132 mm and local-
ized in the IV, VII, and VIII hepatic segments Figure 1); it
also showed the presence of multicystic areas with calcifi-
cations (Figure 2). The lesion was well defined,
hypodense and with a hyperdense rim. The arterial phase
exhibited significant enhancement during the arterial
phase, decreasing during the portal phase, until becoming
isodense relative to the liver in delayed scans. CT findings
were characteristic for a giant hepatic adenoma. Since the
diagnostic work-up supported the hypothesis of a hepatic
adenoma, the surgical treatment was advocated. In this
case surgery was the only therapeutic option. In fact,
hepatic adenomas larger than 5 cm should be surgically
removed due to the risk of hemorrhage and/or malignant
transformation. No pre-operative biopsy was performed
since its outcome would not have influenced the surgical
treatment.
The patient was brought to the OR and a bilateral subcos-
tal incision was performed. A voluminous hepatic lesion
involving IV, VII and IVb segments was found. There was
a first attempt to enucleate the mass from the surrounding
liver parenchyma. However, since the mass was closely
adherent to the right and middle hepatic veins, a liver
resection was carried out. After performing the Pringle
maneuver, parenchymal dissection was accomplished
using the cavitational ultrasonic surgical aspirator.
Hemostasis was achieved using argon beam coagulator,
bipolar forceps and suture ligatures.
The specimen measured 19 × 15 × 7 cm. The mass
appeared as a well circumscribed green-brown colored
tumour with hemorrhagic areas and a cyst of 6 cm in
diameter, with macroscopic calcification within. The sur-
rounding liver tissue was normal.
Microscopically, the lesion was composed of mature
hepatocytes organized in sheets, mainly 2 cells thick. The
cells had large cytoplasms and round nuclei with incon-
spicuous nucleoli. Some bi-nucleated cells were present.
Gomori's staining showed that reticulin production was
preserved within the proliferation. No vascular invasion
was present. Large areas of hemorrhage and focal dilata-
tion of peliosis-like sinusoid were present. A cystic forma-
tion with fibrotic and focally calcified wall was found
within the lesion. Histologically, in the context of the
wall, lamellar bone forming trabeculae intermingled with
Contrast-enhanced CT scanFigu e 2
Contrast-enhanced CT scan. A: adenoma; RHV: right hepatic 
vein; MHV: middle hepatic vein (portal venous phase).
Contrast-enhanced CT scanFigu e 1
Contrast-enhanced CT scan. A: adenoma; Cy: cyst; C: calcifi-
cations within the cystic lesion (arterial phase);.Page 2 of 4
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marrow metaplasia) were found (Figure 3 and 4). CD 34
immunostaining was negative. Therefore, a diagnosis of
hepatocellular adenoma was established.
The patient started oral intake on 4th postoperative day,
with a carbohydrate-based diet. No signs of liver failure
were recorded and the patient was discharged on day 13
post-op, after removing the J-P drains.
Discussion
Among benign tumors of the liver, the hepatocellular ade-
noma is the most common. Its annual incidence is one
case for 1 million persons per year. Three cases for
100,000 people per year occur among women who have
had exposure to oral contraceptives. Risk increases with
length of exposure to oral contraceptive[1,2]. Withdrawal
of oral contraceptives is reported to induce the regression
of the tumor, although this may take several months[3].
Another risk group for hepatic adenoma includes patients
with glycogen storage disease: the prevalence is 50% in
patients with type I glycogen storage disease and 25%
with type III disease. In these patients, adenomas are also
more likely to be multiple and to undergo malignant
transformation [4]. Adenomas can also be found in asso-
ciation with other conditions such as diabetes mellitus,
pregnancy, anabolic steroids, Fanconi anemia, Hurler dis-
ease, familial adenomatous polyposis and tyrosinemia.
Most of these tumors are detected incidentally by ultra-
sound or other scanning techniques. Others are discov-
ered because of hepatomegaly, right upper quadrant
discomfort, or intraperitoneal hemorrhage and the diag-
nosis is sometimes established only at laparotomy. Liver
function tests are usually normal or only slightly elevated
[5]. Ultrasound, CT scan and MRI can be employed as
imaging techniques. In particular CT scan can show a well
circumscribed and often encapsulated mass that has a low
density on non-contrast phase, a marked centripetal pat-
tern of enhancement on arterial phase and a central
necrotic area or calcifications[6].
At gross examination, hepatic adenoma is typically a well
circumscribed and encapsulated tumor with soft consist-
ency and a size ranging from less than 1 cm to over 20 cm
in diameter[7].
Microscopically, the hallmark of adenomas is the normal
appearance of the hepatocytes. These are arranged in
sheets and have no malignant features; these cells tend to
be larger than normal hepatocytes and their cytoplasm
often contain fat or glycogen. Areas of thrombosis and inf-
arction may be observed.
In this case the unusual characteristic of the tumor was the
presence of bone marrow metaplasia. The presence of
bone marrow metaplasia could be explained by the effort
of the liver to regenerate damaged hepatic tissue[8]. It has
already been demonstrated that marrow-derived stem
cells could be attracted by the damaged liver tissue upon
releasing of cytokines and migration factors. At that point,
stem cell could differentiate into hepatic progenitor cells
and then into mature hepatocytes. Hepatic progenitor
cells have been found in hepatic adenomas, as well as in
hepatocellular carcinoma, hepatitis B virus induced cir-
rhosis, focal nodular hyperplasia, in small cell dysplastic
Optical microscopy (20×)Figure 4
Optical microscopy (20×). Bone marrow metaplasia: lamellar 
bone forming a trabecula (L), adipose tissue (AT), and hemo-
poietic cells (*). Osteocytes are evident in the lacunae (>).
Optical microscopy (20×)Figure 3
Optical microscopy (20×). Lamellar bone (L) found in the 
context of the fibrotic wall of a cyst present within the ade-
noma. Osteoclast (o – multinucleated cells) can be observed 
on the border of the trabeculae.Page 3 of 4
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cate that hepatic progenitor cells may play a role in
human liver tumor development. In conclusions, in our
case it is possible to speculate that the presence of mar-
row-derived hepatic progenitor cells might be the source
of both adenoma hepatocytes and bone marrow differen-
tiated cells.
To our knowledge, this is the second case in the literature
that bone marrow metaplasia has been associated with a
hepatocellular adenoma. The first time it was discovered
in a glycogen-storage disease-associated hepatic ade-
noma[10].
Differentiation of hepatocellular adenoma from high-
grade hepatocellular carcinoma (HCC) can be difficult,
and sometimes impossible. Adenoma tends to lack malig-
nant-appearing mitotic structures and no cellular invasion
into the capsule or surrounding liver parenchyma occurs.
Unfortunately, these features may be absent in HCC, espe-
cially if it is well differentiated[7]. The diagnosis of
hepatic adenoma is usually made when findings of malig-
nancy are absent.
Even though the hepatic adenoma is not a malignant
tumor, surgical intervention may be required to establish
a histological diagnosis of the liver mass or if sudden mas-
sive bleeding or liver failure occur[11,12]. Because liver
surgery had historically been associated with high rates of
morbidity and mortality, non-operative management of
benign liver lesions was commonplace. However,
advances in anesthesia, surgical technique and post-oper-
ative care have produced dramatically improved out-
comes after hepatic resection, allowing the routine
inclusion of surgery as a therapeutic option[11,12]. Con-
troversy remains only for hepatic adenomas smaller than
5 cm in diameter. In the present case surgical treatment
was the only therapeutic option, considering that this
voluminous adenoma could easily lead to massive hem-
orrhage or malignant transformation.
Conclusion
It has been demonstrated that marrow-derived stem cells
could be attracted by the damaged liver tissue upon releas-
ing of cytokines and migration factors In conclusions, in
our case it is possible to speculate that the presence of
marrow-derived hepatic progenitor cells might be the
source of both adenoma hepatocytes and bone marrow
differentiated cells.
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